Ferritin Accumulation in the Brain and Its Connection to Hemochromatosis and Neuroferritinopathy Introduction

By

Ferritin is the primary intracellular protein responsible for storing iron safely and maintaining iron homeostasis. It also acts as an acute-phase reactant, meaning its levels increase during inflammation and infection. Therefore, elevated ferritin can reflect both increased iron storage and changes in inflammatory activity.

This relationship is particularly relevant in COVID-19. Researchers studied 144 hospitalized COVID-19 patients with different disease severities and compared them with 139 individuals without COVID-19. COVID-19 patients showed significantly increased inflammatory markers, including IL-6, S100A8/A9, and CRP. Iron metabolism was also altered: ferritin and hepcidin increased, while circulating iron and transferrin decreased, with these changes generally becoming more pronounced as disease severity increased. In simple terms, severe COVID-19 appears to cause the body to restrict circulating iron and shift it toward storage, alongside a strong inflammatory response. These changes may contribute to immune dysfunction and could potentially serve as indicators of disease severity.

Ferritin protects cells by storing iron in a non-toxic form, reducing free iron that can generate reactive oxygen species (ROS) through the Fenton reaction. However, disrupted iron regulation and excessive accumulation can promote oxidative stress and cellular damage. This is particularly important in the brain, where abnormal iron accumulation is associated with neurological complications. Conditions involving iron overload include hemochromatosis, a systemic iron-overload disorder, and neuroferritinopathy, a rare inherited neurodegenerative disease characterized by abnormal ferritin and iron accumulation in the brain.

Researchers have also examined gene-expression data from people with long COVID. Their findings suggest that disturbances involving inflammation and iron metabolism may persist in severe long COVID. However, these results are exploratory and do not demonstrate that altered iron metabolism causes long COVID.

Overall, the close relationship between ferritin, inflammation, and iron homeostasis makes ferritin an important biomarker for understanding disease severity, iron-related disorders, and potentially persistent complications following infection.

Hemochromatosis and Ferritin Accumulation

What is Hemochromatosis?

Hemochromatosis is a genetic disorder in which the body absorbs and stores too much iron from the diet. Over time, this leads to excessive iron deposits in various organs, including the liver, pancreas, heart, joints, and potentially the brain.

Causes and Genetics

Most cases of hemochromatosis are due to mutations in the HFE gene, particularly C282Y and H63D variants. These mutations impair the regulation of iron absorption in the gut, leading to chronic iron overload.

Ferritin in Hemochromatosis

Ferritin levels are often elevated in the blood as a reflection of the body’s increased iron stores. In some cases, ferritin may also accumulate in the brain. While hemochromatosis is typically associated with liver damage, diabetes, and heart problems, its neurological implications are less well understood but potentially significant.

Iron Accumulation in the Brain: Mechanisms and Effects

How Does Iron Reach the Brain?

Iron enters the brain through tightly regulated processes involving transferrin and the blood-brain barrier. Once in the brain, it is stored in ferritin. In conditions like hemochromatosis or neuroferritinopathy, these regulatory mechanisms may become overwhelmed or disrupted, leading to abnormal iron deposition.

Consequences of Brain Iron Overload

Iron accumulation in the brain can result in:

  • Oxidative stress

  • Mitochondrial dysfunction

  • Inflammation

  • Neuronal death

Particularly affected regions include the basal ganglia, cerebellum, and cortex, which are critical for motor control and cognitive functions.

Neuroferritinopathy: A Genetic Movement Disorder

Overview

Neuroferritinopathy is a rare, autosomal dominant neurodegenerative disorder caused by mutations in the FTL1 gene, which encodes the light chain of ferritin. This condition is distinct from hemochromatosis but also involves iron dysregulation, specifically in the brain.

Pathophysiology

Mutations in the FTL1 gene impair ferritin’s iron-storage capability, leading to:

  • Excess free iron

  • Ferritin aggregates

  • Oxidative neuronal damage

Unlike hemochromatosis, patients with neuroferritinopathy often have normal or low serum ferritin levels, but show iron and ferritin aggregates in brain tissue.

Clinical Symptoms

Patients usually present in mid-adulthood with:

  • Chorea (involuntary movements)

  • Dystonia (muscle contractions)

  • Tremor

  • Parkinsonism

  • Cognitive decline

  • Psychiatric disturbances

MRI imaging reveals characteristic iron deposition, especially in the basal ganglia.

Neurological Symptoms of Iron Overload

Both hemochromatosis and neuroferritinopathy can lead to neurological symptoms, including:

  • Fatigue and brain fog

  • Mood disturbances (depression, anxiety)

  • Cognitive impairment

  • Movement disorders

  • Sexual dysfunction and hormonal irregularities

These symptoms arise from iron-mediated neurotoxicity and damage to critical brain regions.

Diagnosis

Hemochromatosis

  • Blood tests: Elevated ferritin and transferrin saturation

  • Genetic testing: Identification of HFE mutations

  • MRI imaging: May detect iron deposits in organs including the brain

Neuroferritinopathy

  • Genetic testing: FTL1 gene mutations

  • MRI: Shows iron accumulation in basal ganglia and other regions

  • Serum ferritin: Often low or normal

    A ferritin level above 300–500 ng/mL (micrograms per liter) is generally considered an indicator of inflammation, though the exact threshold can vary depending on the clinical context and patient population.

    1. Normal Ferritin Ranges (Approximate)

  • Men: 30–300 ng/mL

  • Women: 20–200 ng/mL

  • Children: 7–140 ng/mL

        2. Ferritin as an Inflammatory Marker

  • Ferritin >300–500 ng/mL:
    Suggests inflammation, infection, or chronic disease, even if iron stores are not elevated.

  • Ferritin >1000 ng/mL:
    Often seen in serious inflammatory conditions, such as:

    • Sepsis

    • Hemophagocytic lymphohistiocytosis (HLH)

    • Still’s disease

    • Severe COVID-19

    • Liver disease or malignancies

Key Point:

Ferritin is an acute-phase reactant, meaning it rises in response to inflammation regardless of actual iron stores. So elevated ferritin doesn’t always indicate iron overload—it could be due to an inflammatory response.

Treatment Approaches

Hemochromatosis

  • Phlebotomy (bloodletting): Regular blood removal reduces iron levels

  • Iron chelation therapy (in some cases)

  • Dietary adjustments: Limiting iron intake and avoiding supplements

Neuroferritinopathy

  • No definitive cure; management is symptomatic:

    • Movement disorder medications (e.g., levodopa, anticholinergics)

    • Antioxidants or experimental iron-chelators may help slow progression

    • Physical and occupational therapy

Research and Future Directions

Emerging studies suggest that nutritional interventions (e.g., antioxidants, polyunsaturated fatty acids) may help reduce brain iron levels. Iron-chelating agents that can cross the blood-brain barrier are also under investigation. Advances in imaging (such as quantitative susceptibility mapping MRI) allow better visualization of iron deposits in the brain, aiding early diagnosis and monitoring.

Conclusion

Ferritin accumulation in the brain—whether from systemic iron overload as seen in hemochromatosis, or due to localized dysfunction as in neuroferritinopathy—can have serious neurological consequences. While hemochromatosis is more common and often presents with systemic symptoms, neuroferritinopathy is rare but uniquely impacts brain iron handling. Both conditions underscore the delicate balance of iron regulation in the body and the brain. Ongoing research aims to uncover better diagnostic tools and treatments to manage and potentially reverse the effects of brain iron overload.

Reference:

Neuroferritinopathy:
https://medlineplus.gov/genetics/condition/neuroferritinopathy/

Neuroferritinopathy: From ferritin structure modification to pathogenetic mechanism:
https://pmc.ncbi.nlm.nih.gov/articles/PMC4642653/

Neurodegeneration with brain iron accumulation (NBIA)
https://medlineplus.gov/ency/article/001225.htm

Symptoms - Haemochromatosis
https://www.nhs.uk/conditions/haemochromatosis/symptoms/

Ferritin and Neurotoxicity: A Contributor to Deleterious Outcomes for Subarachnoid Hemorrhage https://karger.com/ene/article/85/6/415/823580/Ferritin-and-Neurotoxicity-A-Contributor-to

UK study links key nutrients to reducing brain iron buildup
https://research.uky.edu/news/uk-study-links-key-nutrients-reducing-brain-iron-buildup

HFE : Missense Variant 119 citations for rs1799945
https://www.ncbi.nlm.nih.gov/snp/rs1799945#publications

HFE-AS1 : Non Coding Transcript Variant 21 citations for rs1800730
https://www.ncbi.nlm.nih.gov/snp/rs1800730#publications

Myelodysplastic syndromes (MDS) and Extremity Petechiae
https://swaresearch.blogspot.com/2023/09/myelodysplastic-syndromes-mds-explained.html

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Image
My Journey Toward Understanding Spinal Muscular Atrophy (SMA) Today, I better understand why Spinal Muscular Atrophy (SMA) received so little attention, particularly during the 1950s. This complex and debilitating genetic disorder was poorly understood, and patients’ symptoms could easily be minimized, misinterpreted, or dismissed. Even today, SMA can present significant diagnostic challenges, particularly in adults with complex medical histories. In my own experience, comprehensive investigations into the underlying cause of progressive muscle weakness were not always pursued. A Long and Complicated Diagnostic Journey In 2008, while being investigated for permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II .  I underwent surgery in 2009, but unfortunately, my symptoms did not improve. In 2010, a DNA test identified a genetic marker involving the ACTN3 gene . Further information about ACTN3 and its possible relation...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By
Image
Abstract Post-Polio Syndrome (PPS) develops in some survivors of paralytic poliomyelitis decades after recovery and is characterized by new or progressive muscle weakness, fatigue, pain, and reduced endurance. The prevailing pathophysiological model attributes PPS primarily to the gradual deterioration of enlarged motor units formed through compensatory axonal sprouting after the initial poliovirus (PV) infection. Although immune dysregulation and chronic systemic inflammation have been investigated as potential mechanisms, current evidence does not support classifying PPS as a primarily dysimmune or chronically inflammatory disorder. Nevertheless, the possible persistence of poliovirus-derived material and its biological significance remain subjects of investigation. Evidence for viral persistence has been reported in subsets of patients with PPS. In one study of 47 patients, elevated anti-poliovirus IgM antibodies were detected in some individuals, with titers reaching 1:250 compared...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By
Update: New Research Builds on Previous Findings Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2832234?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=040925&adv= Conclusions: This recent cohort study builds upon earlier work by identifying COVID-related cytokine storm (COVID-CS) through common inflammation markers and comparing it with two other cytokine storm (CS) conditions: malignancy-associated hemophagocytic lymphohistiocytosis (MN-HLH) and CAR-T–associated cytokine release syndrome (CAR-T CRS) . Among the three groups, patients treated with CAR-T therapy showed the highest survival rates , in contrast to those with COVID-CS and MN-HLH. Interestingly, the study found that CAR-T CRS and COVID-CS share similar cytokine activation pathways , suggesting a comparable immune response mechanism. In c...
Read more

The Impact of Acids on Muscular and Vascular Systems: Potential Negative Outcomes

By
This is ongoing research, and updates will be included as soon as they become available. A kidney transplant recipient with acute SARS-CoV-2 infection developed rhabdomyolysis and severe acute kidney injury (AKI) . A muscle biopsy confirmed findings consistent with immune-mediated necrotising myositis. Acid exposure and acid–base imbalances may profoundly affect the muscular and vascular systems. Strong acids from external sources, such as industrial chemicals, can cause corrosive tissue damage, while internal disturbances associated with metabolic disorders may disrupt cellular function and contribute to systemic complications. This article explores the potential effects of external acid exposure and internal acid–base disturbances on muscular and vascular health, including those associated with metabolic or genetic conditions. Because susceptibility to ME/CFS and complications following COVID-19 varies among individuals, further research may help determine whether genetic variant...
Read more

Impact of Penicillium on Muscle and Lung Function: What Healthcare Professionals Should Know

By
Image
Introduction While symbiotic relationships between viruses and bacteria have been documented, the possibility of a symbiosis between COVID-19 (SARS-CoV-2) and common fungal genera such as Penicillium , Aspergillus , and Trichoderma remains unexplored. This gap in research presents a potential area of interest for understanding novel microbial interactions and their implications for human health. Symbiosis Between Viruses and Bacteria – A Fascinating Partnership in the Microbial World https://swaresearch.blogspot.com/2025/07/symbiosis-between-viruses-and-bacteria.html When viruses, bacteria, or fungi—such as Penicillium —enter a host, they can trigger a range of immune responses and physiological disruptions.  Penicillium molds do not directly produce autoantibodies. However, exposure to Penicillium mold and its mycotoxins can trigger an immune response that may lead to the production of IgG antibodies , including those that could be reactive against the body's own tissues ,...
Read more